NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page
11th February 2025 – Happy International Day of Women and Girls in Science!

11th February 2025 – Happy International Day of Women and Girls in Science!

Why do we celebrate this? – To inspire and engage others to pursue science, technology, engineering, and mathematics – To improve gender equality in science – To highlight the role of women and girls in science and technology communities – To...
Neuro-Bio new publication – A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice

Neuro-Bio new publication – A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice

Our latest study, published in Neurobiology of Aging, investigates the role of the novel peptide T14 in age-dependent behaviours using female mice models. The findings highlight significant variations in T14 levels with age, shedding light on potential mechanisms...
Baroness Greenfield attends Club Vita Webinar “The Risk of Living Longer S02 E04: Preventing Dementia”

Baroness Greenfield attends Club Vita Webinar “The Risk of Living Longer S02 E04: Preventing Dementia”

Their final episode of season two rounded out the theme of prevention by focusing on an area of significant impact for many of us personally and professionally. Baroness Susan Greenfield (Neuro-Bio Ltd) spoke about and explored the possibilities for preventing...
Baroness Greenfield’s Interview at La Vanguardia – A Spanish Newspaper, based in Barcelona talking about Alzheimer’s Disease

Baroness Greenfield’s Interview at La Vanguardia – A Spanish Newspaper, based in Barcelona talking about Alzheimer’s Disease

“In six months we will have the test for Alzheimer’s, and in two months, the cure!” Baroness Greenfield talks about Alzheimer’s Disease, and the focus on discovering a test and a cure! To read the full interview, with the option to translate,...
Baroness Greenfield’s Presentation at Brain Innovation Days in Brussels – November 2024!

Baroness Greenfield’s Presentation at Brain Innovation Days in Brussels – November 2024!

BLOWING THE MIND, EXPANDING THE MIND & LOSING THE MIND The human brain becomes highly personalized after birth by the development of unique configurations of connections between the brain cells that characterize its subsequent growth, personalizing it into what we...
Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective  Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14...
« Older Entries
Next Entries »

LATEST NEWS

  • Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab!
  • Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield attends DC Finance’s Global Family Office & High Net Worth Community 2025 London Conference
  • Meeting with Prof. Lorna Harries at the University of Exeter to review progress and plan next experiments
  • Our Office Manager Charles Monro attended the new opening of the reception area at UK Atomic Energy Authority
  • Neuro-Bio welcomes back Adam Khan

TOPICS

  • Latest News
  • Media

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025